EPITHELIAL OVARIAN CANCER
Clinical trials for EPITHELIAL OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new EPITHELIAL OVARIAN CANCER trials appear
Sign up with your email to follow new studies for EPITHELIAL OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough ovarian cancer? trial tests targeted drug vs standard chemo
Disease control TerminatedThis study tested a new drug, luveltamab tazevibulin, against standard chemotherapy in 600 women with ovarian cancer that had stopped responding to platinum-based treatment. The drug targets a protein called FOLR1 found on cancer cells. The trial was terminated early, so results …
Matched conditions: EPITHELIAL OVARIAN CANCER
Phase: PHASE2, PHASE3 • Sponsor: Sutro Biopharma, Inc. • Aim: Disease control
Last updated May 17, 2026 00:25 UTC
-
Experimental cancer therapy trial halted after just one patient
Disease control TerminatedThis early-stage study tested a new cell therapy called ITIL-306 for people with advanced solid tumors (ovarian, lung, or kidney cancer) that had stopped responding to standard treatments. The therapy used a patient's own immune cells, modified to better attack tumors. The trial …
Matched conditions: EPITHELIAL OVARIAN CANCER
Phase: PHASE1 • Sponsor: Instil Bio • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Early cancer drug trial halted after just 3 patients
Disease control TerminatedThis was a very early (Phase 1) study testing a new drug called AMG 794 in adults with advanced lung, ovarian, or other solid tumors that had a specific marker (claudin 6). The main goal was to check safety and find the right dose. The study was stopped early after only 3 people …
Matched conditions: EPITHELIAL OVARIAN CANCER
Phase: PHASE1 • Sponsor: Amgen • Aim: Disease control
Last updated May 12, 2026 13:39 UTC